Small Intestinal Bacterial Overgrowth: A Possible Association with Fibromyalgia

REFERENCES

• Wolfe F, Smythe H A, Yunus M B, Bennet R M, Bombardier C, Goldenberg D L, Tugwell P, Campbell S M, Abeles M, Clark P, Fam A G, Farber S J, Fiechtne J J, Franklin C M, Gatter RA, Hamaty D, Lessard J, Lichtbroun A S, Masi A T, McCain G A, Reynolds W J, Romano T J, Russell I J, Sheon R P. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum, 33: 160–72, 1990
   PubMed Web of Science ®Google Scholar
• Triadafilopoulos G, Simms R W, Goldenberg D I. Bowel dysfunction in fibromyalgia syndrome. Dig Dis Sci 1991; 36: 59–64
   PubMed Web of Science ®Google Scholar
• Hudson J I, Goldenberg D L, Pope HG, Jr., Keck PE, Jr., Schlesinger L. Co-morbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992; 92: 363–7
   PubMed Web of Science ®Google Scholar
• Veale D, Kavanagh G, Fielding J F, Fitzgerald O. Primary fibromyalgia and the irritable bowel syndrome: Different expressions of a common pathogenetic process. Br J Rheumatol 1991; 30: 220–2
   PubMedGoogle Scholar
• Functional gastro intestinal disorders: Diagnosis, pathophysiology and treatment: A multinational consensus, D A Drossman, J E Richter, N Talley. Little, Brown, Boston 1994
   Google Scholar
• Machtey I. Chlamydia pneumoniae antibodies in myalgia of unknown cause [including fibromyalgia]. Br J Rheumatol 1997; 36: 1134
   PubMedGoogle Scholar
• Steere A C. Musculoskeletal manifestations of Lyme disease. Am J Med 1995; 98: 44, S-48S
   Google Scholar
• Schned E S, Williams D N. Special concerns in Lyme disease. Seroposivity with vague symptoms and development of fibrositis. Postgrad Med 1992; 91: 65–68, 70
   PubMed Web of Science ®Google Scholar
• Sigal L H. Summary of the first 100 patients seen at a Lyme disease referral center. Am J Med 1990; 88: 577–581
   PubMed Web of Science ®Google Scholar
• Berg R D, Wommack E, Deitch E A. Immunosuppression and intestinal bacterial over growth synergistically promote bacterial translocation. Arch Surg 1988; 123: 1359–64
   PubMedGoogle Scholar
• Wells C L, Barton R G, Jechorek R P, Cerra F B. Effect of three liquid diets on cecal bacterial flora and bacterial translocation in mice. Nutrition 1991; 7: 358–63
   PubMedGoogle Scholar
• Guarner C, Runyon B A, Young S, Heck M, Sheikh M Y. Intestinal bacterial over growth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997; 26: 1372–8
   PubMed Web of Science ®Google Scholar
• Nieuwenhuijs V B, Verheem A, van Duijvenbode-Beumer H, Visser M R, Verhoef J, Gooszen H G, Akkermans L M. The role of interdigestive small bowel motility in the regulation of gut microflora, bacterial over growth, and bacterial translocation in rats. Ann Surg 1998; 228: 188–93
   PubMed Web of Science ®Google Scholar
• Lichtman S N, Keku J, Clark R L, Schwab J H, Sartor R B. Biliary tract diseases in rats with experimental small bowel bacterial over growth. Hepatology 1990; 13: 766–72
   Google Scholar
• Lichtman S N, Sartor R B, Keku J, Schwab J H. Hepatic inflammation in rats with experimental small intestinal bacterial over growth. Gastroenterology 1990; 98: 414–23
   PubMed Web of Science ®Google Scholar
• Riordan S M, McIvor C J, Williams R. Liver damage in human small intestinal bacterial over growth. Am J Gastroenterology 1998; 93: 234–7
   PubMedGoogle Scholar
• Maier S F, Wiertelak E P, Martin D, Watkins L R. Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res 1993; 623: 321–4
   PubMedGoogle Scholar
• Watkins L R, Wiertelak E P, Goehler L, Mooney-Heiberger K, Martinez J, Furness L, Smith K D, Maier S F. Neurocircuitry of illness-induced hyperalgesia. Brain Res 1994; 639: 283–299
   PubMedGoogle Scholar
• Watkins L R, Wiertelak E P, Furness L E, Maier S F. Illness-induced hyperalgesia is mediated by spinal neuropeptides and excitatory amino acids. Brain Res 1994; 664: 17–24
   PubMedGoogle Scholar
• Wiertelak E P, Smith K P, Furness L, Moo ney Heiberger K, Mayr T, Maier S F, Watkins L R. Acute and conditioned hyperalgesic responses to illness. Pain 1994; 56: 227–34
   PubMed Web of Science ®Google Scholar
• Kanaan S A, Saade N E, Haddad J J, Abdelnoor A M, Atweh S F, Jabbur S J, Safieh-Garabedian B. Endotoxin-induced local inflammation and hyperalgesia in rats and mice: A new model for inflammatory pain. Pain 1996; 66: 373–9
   PubMedGoogle Scholar
• Cahill C M, Dray A, Coderre T J. Priming enhances endotoxin-induced thermal hyperalgesia and mechanical allodynia in rats. Brain Res 1998; 808: 13–22
   PubMedGoogle Scholar
• Walker K, Dray A, Perkins M. Development of hyperthermia and hyperalgesia following intracerebroventricular administration of endotoxin in the rat: Effect of kinin B1 and B2 receptor antagonists. Immunopharmacology 1996; 33: 264–9
   PubMedGoogle Scholar
• Walker K, Dray A, Perkins M. Hyperalgesia in rats following intracerebroventricular administration of endotoxin: Effect of bradykinin B1 and B2 receptor antagonists. Pain 1996; 65: 211–9
   PubMedGoogle Scholar
• Burckhardt C S, Clark S R, Bennett R M. The fibromyalgia impact questionnaire: Development and validation. J Rheumatol 1991; 18: 728–33
   PubMed Web of Science ®Google Scholar